AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Bilastine in South Africa
1 product registered with SAHPRA — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ILAXTEN ORAL SOLUTION | 55/5.7.1/0006 | LeBasi Pharmaceuticals (Pty) Ltd | active | 4 Jun 2029 |
Bilastine — SAHPRA Registration Details
SAHPRA (South Africa) has 1 registered product containing Bilastine, of which 1 is currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Bilastine registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.